[This corrects the article on p. 462 in vol. 13, PMID: 33594304.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251001 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Erratum: Genome-wide target interactome profiling reveals a novel epigenetic pathway for oncogenic lncRNA in breast cancer.
Am J Cancer Res
September 2023
Stem Cell and Cancer Center, The First Hospital of Jilin University 71 Xinmin Street, Changchun 130021, Jilin, China.
[This corrects the article on p. 714 in vol. 9, PMID: 31105998.
View Article and Find Full Text PDFCorrection: LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2.
Cell Death Dis
August 2023
Department of Maxillofacial and Otorhinolaryngological Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Erratum: LncRNA-MALAT1, as a biomarker of neonatal BPD, exacerbates the pathogenesis of BPD by targeting miR-206.
Am J Transl Res
May 2023
Neonatal Intensive Care Unit, Zhoukou Central Hospital Zhoukou 466000, Henan, China.
[This corrects the article on p. 462 in vol. 13, PMID: 33594304.
View Article and Find Full Text PDFCorrigendum to "Knockdown of lncRNA MALAT1 promotes bupivacaine-induced neurotoxicity via the miR-101-3p/PDCD4 axis" [Life Sci. 232 (2019) 116606].
Life Sci
July 2020
Department of Anesthesiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!